Differential resistance to platinum-based drugs and 5-fluorouracil in p22phox-overexpressing oral squamous cell carcinoma: Implications of alternative treatment strategies

Platinum-based drugs: past, present and future

(2016) Shahana Dilruba et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

p22phox confers resistance to cisplatin, by blocking its entry into the nucleus

(2015) Chih-Chang Hung et al.   Oncotarget

Cisplatin-induced ototoxicity: Transporters playing a role in cisplatin toxicity

(2013) Sofia Waissbluth et al.   HEARING RESEARCH

NADPH oxidase activation in pancreatic cancer cells is mediated through Akt-dependent up-regulation of p22phox.

(2013) Mouad Edderkaoui et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma

(2013) Wei-Fan Chiang et al.   ORAL ONCOLOGY

Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update

(2012) Neife Aparecida Guinaim dos Santos et al.   ARCHIVES OF TOXICOLOGY

Oxaliplatin: a review in the era of molecularly targeted therapy

(2011) T. Alcindor et al.   Current Oncology

Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma

(2011) Lo-Lin Tsai et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

The NADPH Oxidase Subunit p22phox Inhibits the Function of the Tumor Suppressor Protein Tuberin

(2010) Karen Block et al.   AMERICAN JOURNAL OF PATHOLOGY

The status of platinum anticancer drugs in the clinic and in clinical trials

(2010) Nial J. Wheate et al.   DALTON TRANSACTIONS

Platinum neurotoxicity pharmacogenetics

(2009) S. R. McWhinney et al.   MOLECULAR CANCER THERAPEUTICS

EGFR Inhibitor Enhances Cisplatin Sensitivity of Oral Squamous Cell Carcinoma Cell Lines

(2009) Yukihiro Hiraishi et al.   PATHOLOGY & ONCOLOGY RESEARCH

Cisplatin and Oxaliplatin Toxicity: Importance of Cochlear Kinetics as a Determinant for Ototoxicity

(2008) V. Hellberg et al.   JNCI-Journal of the National Cancer Institute

Current concepts for the management of head and neck cancer: Chemotherapy

(2008) Pol M. Specenier et al.   ORAL ONCOLOGY